1Ozawa Y.Edema in endocrine and metabolic diseases.Nippon Rinsho,2005,63(1):85-90.
2Vora JP,Ibrahim HA,Bakris GL.Responding to the challenge of diabetic nephropathy:the historic evolution of detection,prevention and management.J Hum Hypertens,2000,14:667-685.
4Shumway JT,Gambert SR.Diabetic nephropathy-pathophysiology and management.Int Urol Nephrol,2002,34(2):257-264.
5Malchesky PS, Koo AP, Roberson GA, et al. Apheresis technologies and clinical applications: the 2002 international apheresis registry. Ther Apher Dial, 2004,8:124-136.
6Matic G, Winkler RE, Tiess M, et al. Selective apheresistime for a change. Artif Organs, 2001, 24:4-7.
7Braun N, Bosch T. Immunoadsorption, current status and future developments. Exp Opin Invest Drug, 2000,9:2017-2038.
8Schuff-Werner P, Holdt B. Selective hemapheresis, an effective new approach in the therapeutic management of disorders associated with rheological impairment: mode of action and possible clinical indications. Artif Organs, 2002, 26:117-123.
9McCarthy LJ. Evidence-based medicine for apheresis: an ongoing challenge. Ther Apher Dial, 2004, 8:112-123.
